Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics.

Bicikova M, Hampl R, Hill M, Ripova D, Mohr P, Putz Z.

Neuro Endocrinol Lett. 2011;32(2):141-7.

PMID:
21552193
[PubMed - indexed for MEDLINE]
2.

Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.

Iancu I, Tchernihovsky E, Maayan R, Poreh A, Dannon P, Kotler M, Weizman A, Strous RD.

Eur Neuropsychopharmacol. 2007 Jul;17(8):541-5. Epub 2007 Mar 8.

PMID:
17346944
[PubMed - indexed for MEDLINE]
3.

Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder.

Gallagher P, Watson S, Smith MS, Young AH, Ferrier IN.

Schizophr Res. 2007 Feb;90(1-3):258-65. Epub 2007 Jan 11.

PMID:
17222537
[PubMed - indexed for MEDLINE]
4.

The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia.

Ryan MC, Flanagan S, Kinsella U, Keeling F, Thakore JH.

Life Sci. 2004 Mar 5;74(16):1999-2008. Erratum in: Life Sci. 2004 Oct 22;75(23):2851.

PMID:
14967195
[PubMed - indexed for MEDLINE]
5.

Health resort treatment improved the neurosteroid profile in thyroidectomized women.

Jandova D, Bicikova M, Hill M, Hampl R.

Endocr Regul. 2008 Mar;42(1):17-22.

PMID:
18333700
[PubMed - indexed for MEDLINE]
6.

Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia.

Albayrak Y, Beyazyüz M, Beyazyüz E, Kuloğlu M.

Nord J Psychiatry. 2014 Jul;68(5):341-6. doi: 10.3109/08039488.2013.839739. Epub 2013 Oct 7.

PMID:
24094029
[PubMed - indexed for MEDLINE]
7.

Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia.

Ritsner M, Gibel A, Maayan R, Ratner Y, Ram E, Biadsy H, Modai I, Weizman A.

Neuropsychopharmacology. 2005 Oct;30(10):1913-22.

PMID:
15870835
[PubMed - indexed for MEDLINE]
Free Article
8.

Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics.

Dakhale G, Khanzode S, Khanzode S, Saoji A, Khobragade L, Turankar A.

Neuropsychobiology. 2004;49(4):205-9.

PMID:
15154399
[PubMed - indexed for MEDLINE]
9.

Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.

Qi LY, Xiu MH, Chen da C, Wang F, Kosten TA, Kosten TR, Zhang XY.

Neurosci Lett. 2009 Sep 22;462(2):113-7. doi: 10.1016/j.neulet.2009.06.019. Epub 2009 Jun 17.

PMID:
19539717
[PubMed - indexed for MEDLINE]
10.

Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.

Zhang XY, Zhou DF, Cao LY, Wu GY, Shen YC.

Neuropsychopharmacology. 2005 Aug;30(8):1532-8.

PMID:
15886721
[PubMed - indexed for MEDLINE]
Free Article
11.

Alterations in DHEA metabolism in schizophrenia: two-month case-control study.

Ritsner M, Gibel A, Ram E, Maayan R, Weizman A.

Eur Neuropsychopharmacol. 2006 Feb;16(2):137-46. Epub 2005 Sep 1.

PMID:
16139994
[PubMed - indexed for MEDLINE]
12.

Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia.

Bicikova M, Hill M, Ripova D, Mohr P, Hampl R.

J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24.

PMID:
22944140
[PubMed - indexed for MEDLINE]
13.

The effects of atypical antipsychotics on serum prolactin levels.

Hamner M.

Ann Clin Psychiatry. 2002 Sep;14(3):163-73. Review.

PMID:
12585566
[PubMed - indexed for MEDLINE]
14.

Effect of antipsychotics on pituitary gland volume in treatment-naïve first-episode schizophrenia: a pilot study.

MacMaster FP, El-Sheikh R, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan M.

Schizophr Res. 2007 May;92(1-3):207-10. Epub 2007 Mar 6.

PMID:
17337162
[PubMed - indexed for MEDLINE]
15.

Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan.

Huang TL, Chen JF.

Schizophr Res. 2005 Dec 1;80(1):55-9. Epub 2005 Jun 17.

PMID:
15964176
[PubMed - indexed for MEDLINE]
16.

Effects of plasma magnesium and prolactin on quantitative ultrasound measurements of heel bone among schizophrenic patients.

Renn JH, Yang NP, Chou P.

BMC Musculoskelet Disord. 2010 Feb 17;11:35. doi: 10.1186/1471-2474-11-35.

PMID:
20163720
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics.

Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP.

Schizophr Res. 2002 Nov 1;58(1):1-10.

PMID:
12363384
[PubMed - indexed for MEDLINE]
18.

Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months' treatment with quetiapine.

Aggernaes B, Glenthoj BY, Ebdrup BH, Rasmussen H, Lublin H, Oranje B.

Int J Neuropsychopharmacol. 2010 Nov;13(10):1383-95. doi: 10.1017/S1461145710000787. Epub 2010 Jul 16.

PMID:
20633319
[PubMed - indexed for MEDLINE]
19.

Elevation of prolactin levels by atypical antipsychotics.

Turrone P, Kapur S, Seeman MV, Flint AJ.

Am J Psychiatry. 2002 Jan;159(1):133-5.

PMID:
11772702
[PubMed - indexed for MEDLINE]
20.

A study of serum prolactin levels in schizophrenia: comparison of males and females.

Kuruvilla A, Peedicayil J, Srikrishna G, Kuruvilla K, Kanagasabapathy AS.

Clin Exp Pharmacol Physiol. 1992 Sep;19(9):603-6.

PMID:
1356671
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk